Good morning :)

Tickertape - Financial freedom begins here

Thu
Fri
Mon
Tue
Today7:50PM

Market and sectors

See All
NIFTY 50
25,665.600.26%
USD/INR
90.340.07%
Gold
0.00100.00%
NIFTY 100 Largecap
26,256.300.15%
NIFTY 100 Midcap
59,770.500.29%
NIFTY 100 Smallcap
17,410.850.67%
NIFTY Bank
59,580.150.00%
NIFTY IT
37,822.701.08%
NIFTY Pharma
22,505.400.25%
Today's stocks
  • Large Cap
  • switcher
STOCKSPRICECHANGE

179.277.87%

watchlist

675.756.05%

watchlist

654.203.87%

watchlist

189.253.66%

watchlist

846.403.50%

watchlist

Mutual funds and ETFs

  • 1Y Return
  • switcher
FUNDSRETURNS
Equity
Growth
watchlist
Equity
Growth
watchlist
Equity
Growth
watchlist
Equity
Growth
watchlist
Equity
Growth
watchlist
native-add
native-add
native-add
native-add
native-add

Market and sectors

See All
NIFTY 50
25,665.600.26%
USD/INR
90.340.07%
Gold
0.00100.00%
NIFTY 100 Largecap
26,256.300.15%
NIFTY 100 Midcap
59,770.500.29%
NIFTY 100 Smallcap
17,410.850.67%
NIFTY Bank
59,580.150.00%
NIFTY IT
37,822.701.08%
NIFTY Pharma
22,505.400.25%
Today's stocks
  • Large Cap
  • switcher
STOCKSPRICECHANGE

179.277.87%

watchlist

675.756.05%

watchlist

654.203.87%

watchlist

189.253.66%

watchlist

846.403.50%

watchlist

Curated screens and deals

Today's news and events
  • Market
  • switcher
Corporate
RSYSTEMSR Systems expands GCC footprint with launch of GCC Copilot and new facility in Mexico

R Systems has launched GCC Copilot, a transformative AI-assisted service designed to help mid-market and large enterprises launch, scale, and optimize Global Capability Centers (GCCs) with unmatched speed and AI-powered intelligence. The company has also expanded its GCC footprint with the launch of a new facility in Mexico and the enhancement of its Romania center, further strengthening its ability to serve customers across North America and Europe. Organizations across the world are facing significant challenges to remain relevant, especially with rapid adoption of AI. With two decades of proven, multi-model GCC track records for SaaS scale-ups and Fortune 100 companies across the world, R Systems'f GCC Copilot is a proprietary framework and accelerator designed to empower businesses. The low-risk, agile, and AI-infused roadmap helps build and scale high-impact GCCs that can help enterprises meet their innovation goals with the right skillsets and experience. Built on R Systems' deep expertise in engineering, AI, and cloud modernization, the service delivers an outcome-driven GCC setup with product expertise, automation-first strategies, assisted runbooks, and seamless scalability, enabling: '- Seamless Product-Mindset Alignment: Cultural alignment, collaboration, and rapid onboarding are driven by a product-first approach. '- Early Cost-Benefit Realization: Value is delivered quickly through optimized hiring, lean governance, and operational efficiency. '- Best-in-Class Digital Teams: Teams are built from vetted talent pools focused on advanced engineering principles, intelligent automation, and innovation-led delivery excellence, enabling faster time-to-market and up to 30% cost reduction. '- Rapid GCC Setup: Operations are up and running within 90 days with curated playbooks across compliance, operations, talent, and infrastructure. '- Productivity From Day One: AI-powered frameworks automate operational decision making, OKR tracking, and talent productivity metrics.' - Custom Blueprints: Tailored solutions are aligned to each customer's growth stage, industry, and technology priorities. '- Scalable Innovation: Integrations with top startup ecosystems and academic institutions help to drive co-innovation at scale.Powered by Capital Market - Live

7 hours agoCapital Market - Live
Corporate
DRREDDYDr. Reddy's launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7%

Dr. Reddy's Laboratories announced the launch of over-the-counter (OTC) Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7%, the generic equivalent of Extra Strength Pataday' Once-Daily Relief, in the U.S. market, as approved by the U.S. Food and Drug Administration (USFDA). Dr. Reddy's Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% is an Antihistamine eye drop, indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander. Powered by Capital Market - Live

7 hours agoCapital Market - Live
Corporate
TRANSRAILLTransrail Lighting secures new orders of Rs 527 cr

Transrail Lighting has secured new orders aggregating to Rs 527 crore. These wins, spanning the T&D and Poles & Lighting segments, mark a significant milestone in the Company's global expansion journey, further strengthening its presence across the MENA region and Africa while adding manufactured HTLS re-conductoring capability in India to its portfolio. With these additions, Transrail's cumulative order inflows for FY26 have reached Rs 5,637 crore, reflecting sustained momentum across domestic and international markets. In addition, the Company currently holds an L1 position of more than Rs 2,800 crore, providing strong visibility on prospective inflows. Powered by Capital Market - Live

7 hours agoCapital Market - Live
See All

Ready-made PortfoliosInvestment Products

bysmallcase logosmallcase

Mutual funds and ETFs

  • 1Y Return
  • switcher
FUNDSRETURNS
Equity
Growth
watchlist
Equity
Growth
watchlist
Equity
Growth
watchlist
Equity
Growth
watchlist
Equity
Growth
watchlist

Money
Matters

Everything you need to redefine your investing experience
  • Assets tracked worth
    60,500 Cr
  • Loved by
    60 L+ investors
  • Downloads
    6.2M+
  • Rated on Google Play
    4.2